Geri-Tussin
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2021-01-26
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 23:37:27
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
In each 5 mL teaspoonful
Guaifenesin - 100 mg
OTC - PURPOSE SECTION
Purpose
Expectorant
INDICATIONS & USAGE SECTION
Uses
- helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
WARNINGS SECTION
Warnings
Do not use
- if you ever had an allergic reaction to any of the ingredients in this product
Ask a doctor before use if you have
- cough that occurs with too much phlegm (mucus)
- cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
Stop use and ask a doctor if cough lasts more than 7 days, comes back or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away
DOSAGE & ADMINISTRATION SECTION
Directions
- do not take more than 6 doses in a 24 hour period
- do not exceed recommended dose
| adults and children 12 years and over | 2 to 4 teaspoonfuls every 4 hours |
| children under 12 years | ask a doctor |
INACTIVE INGREDIENT SECTION
Inactive ingredients: artificial and natural cherry flavor, citric acid, FD&C red #40, menthol, methylparaben, propylene glycol, propylparaben, purified water, sodium citrate, sucralose
OTC - QUESTIONS SECTION
Questions or comments? 1-800-540-3765
DISTRIBUTED BY:
ATLANTIC BIOLOGICALS CORP.
20101 N.E 16TH PLACE
MIAMI, FL 33179
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 310604 | guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 2 |
| 310604 | guaifenesin 20 MG/ML Oral Solution | SCD | 2 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Solution | SY | 2 |
| 310604 | guaifenesin 100 MG per 5 ML Oral Syrup | SY | 2 |
| 310604 | guaifenesin 200 MG per 10 ML Oral Solution | SY | 2 |
| 310604 | guaifenesin 300 MG per 15 ML Oral Solution | SY | 2 |
| 310604 | guaifenesin 400 MG per 20 ML Oral Solution | SY | 2 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0693-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-106a-0266-e053-dadaa90a7c1a | a307a54c-2861-4027-bec4-da8a984d211e |
| 17856-0693-2 | 2023-01-30 | C162847 | 48780-1 | f386c64a-106a-0266-e053-dadaa90a7c1a | a307a54c-2861-4027-bec4-da8a984d211e |
| 17856-0693-3 | 2023-01-30 | C162847 | 48780-1 | f386c64a-106a-0266-e053-dadaa90a7c1a | a307a54c-2861-4027-bec4-da8a984d211e |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0693-1 | Geri-Tussin | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 2 | |
| 17856-0693-1 | Geri-Tussin | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 2 | |
| 17856-0693-2 | Geri-Tussin | 50 in 1 BOX, UNIT-DOSE | LIQUID | 50 | 2 | |
| 17856-0693-2 | Geri-Tussin | 15 mL in 1 CUP, UNIT-DOSE | LIQUID | 15 | 2 | |
| 17856-0693-3 | Geri-Tussin | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 2 | |
| 17856-0693-3 | Geri-Tussin | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0693 | GERI-TUSSIN (GUAIFENESIN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 2 | Legacy NDC, 6 package rows | 20210128_a307a54c-2861-4027-bec4-da8a984d211e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57896-693-04 | ML - Milliliter | 57896-693 | 7f25273f-d1fc-439d-af72-925bd830bb4a | 1 | 2024-07-12 |
| 57896-693-08 | ML - Milliliter | 57896-693 | b5c35bb9-0318-4e23-b8fd-dff274ac9d70 | 1 | 2026-01-08 |
| 57896-693-16 | ML - Milliliter | 57896-693 | 6f03e183-fd4e-458d-b2ab-ebe17daac28b | 1 | 2019-09-05 |
Products#
Every source-derived product name is available through these pages.
- Geri-Tussin
- Guaifenesin
- ANHYDROUS CITRIC ACID
- FD&C RED NO. 40
- MENTHOL
- METHYLPARABEN
- PROPYLENE GLYCOL
- PROPYLPARABEN
- WATER
- SODIUM CITRATE
- SUCRALOSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17856-0693 | 17856-0693-1, 17856-0693-2, 17856-0693-3 |
| 57896-693 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GUAIFENESIN | 495W7451VQ | ACTIB |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| MENTHOL | L7T10EIP3A | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Geri-Tussin | GUAIFENESIN | Geri-Care Pharmaceuticals, Corp | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 2025-12-31 | Warnings | 57896-693 |
| 3326eecf-db1f-4f1d-b0b1-5eb7065841b6 | a307a54c-2861-4027-bec4-da8a984d211e | 2021-01-26 | Warnings | 3326eecf-db1f-4f1d-b0b1-5eb7065841b6 a307a54c-2861-4027-bec4-da8a984d211e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


